Inventor
CHATURVEDULA PRASAD V
US26 patents
⚠️ This page may combine multiple inventors who share the name “CHATURVEDULA PRASAD V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS7384930B2Jun 10, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO21 citations92
US7834007B2Nov 16, 2010
CGRP antagonists
BRISTOL MYERS SQUIBB CO9 citations84
US7569578B2Aug 4, 2009
Heterocyclic anti-migraine agents
BRISTOL MYERS SQUIBB CO14 citations84
US7842808B2Nov 30, 2010
Anti-migraine spirocycles
BRISTOL MYERS SQUIBB CO13 citations83
US7384931B2Jun 10, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO10 citations83
US7314883B2Jan 1, 2008
Anti-migraine treatments
BRISTOL MYERS SQUIBB CO12 citations83
US7754732B2Jul 13, 2010
Spirocyclic anti-migraine compounds
BRISTOL MYERS SQUIBB CO13 citations82
US7220862B2May 22, 2007
Calcitonin gene related peptide receptor antagonists
BRISTOL MYERS SQUIBB CO11 citations81
US7449586B2Nov 11, 2008
Processes for the preparation of CGRP-receptor antagonists and intermediates thereof
BRISTOL MYERS SQUIBB CO4 citations61
US7049323B2May 23, 2006
Amidoheterocycles as modulators of the melanocortin-4 receptor
BRISTOL MYERS SQUIBB CO2 citations61
US6432944B1Aug 13, 2002
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
BRISTOL MYERS SQUIBB CO2 citations54
US7544680B2Jun 9, 2009
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO0 citations51
US7470680B2Dec 30, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO1 citations51
US7470679B2Dec 30, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO0 citations41
VERTEX PHARMA
4 patentsUS6162800ADec 19, 2000
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA25 citations92
US6576614B1Jun 10, 2003
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA7 citations73
US5985838ANov 16, 1999
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA8 citations73
US6407080B2Jun 18, 2002
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA3 citations62